POMPO: Perioperative Muscle Relaxant and Postoperative Outcomes

Sponsor
Air Force Military Medical University, China (Other)
Overall Status
Unknown status
CT.gov ID
NCT04371588
Collaborator
(none)
999
2
20
499.5
25

Study Details

Study Description

Brief Summary

Muscle relaxant is usually needed for surgery. However, the optimal depth of neuro-muscular blockade is still on debate. Deep neuro-muscular blockade may benefit the patients during surgery, but may increase the risk of residual blockade after surgery. Residual blockade has been reported to increase risk of morbidity. In this study, we tend to observe the postoperative outcomes in patients undergoing abdominal surgery under general anesthesia. And to compare the outcomes in patients received different depth of neuro-muscular blockade.

Condition or Disease Intervention/Treatment Phase
  • Other: No Response to Train of Four Stimulation
  • Other: 1-2 Response to Train of Four Stimulation

Study Design

Study Type:
Observational
Anticipated Enrollment :
999 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Effect of Perioperative Muscle Relaxant Model on Postoperative Outcomes in Chinese Patients
Anticipated Study Start Date :
Apr 30, 2020
Anticipated Primary Completion Date :
Dec 30, 2020
Anticipated Study Completion Date :
Dec 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Deep neuro-muscular blockade

Other: No Response to Train of Four Stimulation
No response is observed during Train of Four stimulation monitoring during surgery

Moderate neuro-muscular blockade

Other: 1-2 Response to Train of Four Stimulation
1 to 2 response is observed during Train of Four stimulation monitoring during surgery

Outcome Measures

Primary Outcome Measures

  1. Visual Analogue Scale of pain at rest at 24 hours after surgery [from end of surgery to 24 hours after surgery]

    The intensity of pain is reported by the patient by provide a number between 0 and 10. 0 means no pain, and 10 means unbearable pain. Higher score means stronger pain.

  2. Visual Analogue Scale of pain at cough at 24 hours after surgery [from end of surgery to 24 hours after surgery]

    The intensity of pain is reported by the patient by provide a number between 0 and 10. 0 means no pain, and 10 means unbearable pain. Higher score means stronger pain.

Secondary Outcome Measures

  1. Incidence of patients suffering pain at 24 hours after surgery [from end of surgery to 24 hours after surgery]

  2. Time to flatus [from end of surgery to flatus, on an average of 3 days]

  3. Time to extubation of the endotracheal tube [from end of surgery to removal of the endotracheal tube, on an average of 15 minutes]

  4. Incidence of major postoperative complications [from end of surgery to discharge from the hospital, on an average of 5 days]

    Incidence of major postoperative complications (including myocardial ischemia, pulmonary infection, respiratory failure, brain ischemia)

  5. Satisfaction score of the Surgeon to the condition during surgery [from start of surgery to end of surgery, on an average of 2.5 hours]

    The satisfaction of the Surgeon is measured by a scale from 0-10. 0 is for extremely unsatisfied, 10 is for totally satisfied. Higher score means higher satisfaction. The surgeon is asked to give a number between 0 and 10 to describe his satisfaction.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age ≥18 years old

  • Body mass <18 kg/m2

  • American Society of Anesthesiologists status I-II

  • Patients scheduled for elective laparoscopic colorectal or urological surgery

  • Patients received general anesthesia and muscle relaxant

  • Patients with written informed consent.

Exclusion Criteria:
  • Second surgery during the same admission.

  • Outpatient surgery

  • Retroperitoneal laparoscopic surgery

  • Patients scheduled for mechanical ventilation after surgery

  • Patients scheduled for muscle relaxant other than rocuronium

  • Patients with pregnancy or planned for breeding

  • Patients who are involved in other studies

Contacts and Locations

Locations

Site City State Country Postal Code
1 First Afiliated Hospital of Zhengzhou University Zhengzhou Henan China 450052
2 People's Hospital of Jiangsu Nanjing China

Sponsors and Collaborators

  • Air Force Military Medical University, China

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Zhihong LU, Professor, Air Force Military Medical University, China
ClinicalTrials.gov Identifier:
NCT04371588
Other Study ID Numbers:
  • XJH-A-20290110
First Posted:
May 1, 2020
Last Update Posted:
May 1, 2020
Last Verified:
Apr 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Zhihong LU, Professor, Air Force Military Medical University, China
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 1, 2020